Jafferji I - Search Results

1

ULBP6/RAET1L is an additional human NKG2D ligand.

Eagle RA, Traherne JA, Hair JR, Jafferji I, Trowsdale J. Eagle RA, et al. Among authors: jafferji i. Eur J Immunol. 2009 Nov;39(11):3207-16. doi: 10.1002/eji.200939502. Eur J Immunol. 2009. PMID: 19658097 Free article.

2

Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.

Eagle RA, Flack G, Warford A, Martínez-Borra J, Jafferji I, Traherne JA, Ohashi M, Boyle LH, Barrow AD, Caillat-Zucman S, Young NT, Trowsdale J. Eagle RA, et al. Among authors: jafferji i. PLoS One. 2009;4(2):e4503. doi: 10.1371/journal.pone.0004503. Epub 2009 Feb 18. PLoS One. 2009. PMID: 19223974 Free PMC article.

3

Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

Eagle RA, Jafferji I, Barrow AD. Eagle RA, et al. Among authors: jafferji i. Curr Immunol Rev. 2009 Feb;5(1):22-34. doi: 10.2174/157339509787314369. Curr Immunol Rev. 2009. PMID: 19626129 Free PMC article.

4

ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients.

McGilvray RW, Eagle RA, Rolland P, Jafferji I, Trowsdale J, Durrant LG. McGilvray RW, et al. Among authors: jafferji i. Int J Cancer. 2010 Sep 1;127(6):1412-20. doi: 10.1002/ijc.25156. Int J Cancer. 2010. PMID: 20054857 Free article.

5

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.

de Kruijf EM, Sajet A, van Nes JG, Putter H, Smit VT, Eagle RA, Jafferji I, Trowsdale J, Liefers GJ, van de Velde CJ, Kuppen PJ. de Kruijf EM, et al. Among authors: jafferji i. BMC Cancer. 2012 Jan 18;12:24. doi: 10.1186/1471-2407-12-24. BMC Cancer. 2012. PMID: 22257486 Free PMC article.

6

NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting.

McGilvray RW, Eagle RA, Watson NF, Al-Attar A, Ball G, Jafferji I, Trowsdale J, Durrant LG. McGilvray RW, et al. Among authors: jafferji i. Clin Cancer Res. 2009 Nov 15;15(22):6993-7002. doi: 10.1158/1078-0432.CCR-09-0991. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861434 Free PMC article.

7

Inhibition of epidermal growth factor receptor (EGFR) expression by human cytomegalovirus correlates with an increase in the expression and binding of Wilms' Tumour 1 protein to the EGFR promoter.

Jafferji I, Bain M, King C, Sinclair JH. Jafferji I, et al. J Gen Virol. 2009 Jul;90(Pt 7):1569-1574. doi: 10.1099/vir.0.009670-0. Epub 2009 Mar 25. J Gen Virol. 2009. PMID: 19321755

8

Lag3: From Bench to Bedside.

Aroldi F, Saleh R, Jafferji I, Barreto C, Saberian C, Middleton MR. Aroldi F, et al. Among authors: jafferji i. Cancer Treat Res. 2022;183:185-199. doi: 10.1007/978-3-030-96376-7_6. Cancer Treat Res. 2022. PMID: 35551660 Review.

9

ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood.

Gupta V, Jafferji I, Garza M, Melnikova VO, Hasegawa DK, Pethig R, Davis DW. Gupta V, et al. Among authors: jafferji i. Biomicrofluidics. 2012 Jun 27;6(2):24133. doi: 10.1063/1.4731647. Print 2012 Jun. Biomicrofluidics. 2012. PMID: 23805171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page